New Mitochondrial Protein Catalog Targets Pathogens
Researchers map six diverse species, providing new targets for drug development in neglected tropical diseases.
Updated on Oct. 27, 2026 in Life Sciences
Live Poll
Do you believe fundamental research on diverse organisms is an effective way to advance human medicine?
In September 2026, the MitoTOl Consortium published a comprehensive catalog of mitochondrial proteins for six diverse eukaryotic organisms, including five parasites and the plant Arabidopsis. These findings provide a new map of pathogen-specific proteins that could serve as targets for drug development.
Why it matters
By characterizing these mitochondrial proteomes, researchers have identified proteins in pathogens that are absent in human cells, offering a potential path for developing selective therapies. This work addresses a critical gap in our understanding of molecular diversity across eukaryotic life.
The researchers utilized serial enrichment to isolate mitochondria, followed by data-independent acquisition mass spectrometry and protein correlation profiling to map the proteomes. This expansion moves the field significantly beyond the 2008 MitoCarta inventory of mouse and human proteins.
The players
MitoTOl Consortium
An international research group focused on mapping mitochondrial proteomes across diverse eukaryotic life.
Harvard Medical School
A premier medical research institution hosting the project's lead investigators.
The details
The study employed mass spectrometry — an analytical technique that measures the mass-to-charge ratio of ions — to identify proteins across six species. By purifying mitochondria and using protein correlation profiling, the team mapped the molecular architecture of these organelles to determine their functional components. The analysis suggests that the Last Eukaryotic Common Ancestor possessed mitochondria capable of both aerobic and anaerobic ATP generation, a finding that refines the timeline of endosymbiosis.
Timeline
2 billion years ago: Ancestral host cell engulfed a bacterium to form mitochondria.
2008: Researchers established the MitoCarta inventory for mouse and human species.
2022: The MitoTOl Consortium was officially established.
September 2026: The consortium published its findings in the journal Cell.
The Tech Race
This work advances the field beyond the scope of the 2008 MitoCarta inventory by cataloging the mitochondrial protein diversity of non-human eukaryotes. The consortium aims to build upon these results to support the training of AI models capable of predicting mitoproteomes from genetic sequence alone.
While this research remains in the discovery phase, it establishes the biological groundwork for future drug development targeting neglected tropical diseases. Scientists can now utilize these findings to screen for compounds that inhibit pathogen-specific proteins without affecting human mitochondria.
The takeaway
The MitoTOl Consortium has created a massive reference map for evolutionary biology that effectively triples the number of organisms with documented mitochondrial proteomes. Watch for upcoming research that uses this data to train AI models, which are expected to predict the makeup of 200 additional mitoproteomes.
Further reading
Explore more developments in Life Sciences to understand how genomic and proteomic research is advancing.
More information
View the complete results in the Cell journal publication.
Source note: This article includes information reported by Technology Networks.
Live Poll
Do you believe fundamental research on diverse organisms is an effective way to advance human medicine?
